US Stock MarketDetailed Quotes
MBGPF MOBERG PHARMA AB
- 0.940
- -0.010-1.05%
15min DelayClose Dec 20 16:00 ET
43.89MMarket Cap-24.10P/E (TTM)
0.946High0.940Low25.05KVolume0.942Open0.950Pre Close23.61KTurnover0.05%Turnover RatioLossP/E (Static)46.69MShares4.30052wk High0.52P/B43.89MFloat Cap0.78452wk Low--Dividend TTM46.69MShs Float4.300Historical High--Div YieldTTM0.63%Amplitude0.784Historical Low0.942Avg Price1Lot Size
About MOBERG PHARMA AB Company
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. Its product pipeline includes MOB-015, which is a treatment for nail fungus. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.
Company Profile
SymbolMBGPF
Company NameMOBERG PHARMA AB
Founded2006
CEOMs. Anna Ljung
MarketPink Market
Employees10
Fiscal Year Ends12-31
AddressGustavslundsv?gen 50,5th Floor
CityBromma
ProvinceStockholm
CountrySweden
Zip Code167 51
Phone46-8-522-30-700
Websitehttp://www.mobergderma.se
Company Executives
- Name
- Position
- Salary
- Anna Ljung
- Chief Executive Officer
- --
- Kerstin Valinder Strinnholm
- Chairman of the Board
- --
- Nikolaj Sorensen
- Independent Director
- --
- Hakan Wallin
- Independent Director
- --
- Anders Lundmark
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data